跳至主要内容
临床试验/2023-509156-34-02
2023-509156-34-02招募中4 期

VALIDGFR; method VALIDation and evaluation of non-radioactive methods to measure Glomerular Filtration Rate

Universitair Medisch Centrum Groningen1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2024年6月5日最近更新:
相关药物

试验速览

阶段
4 期
状态
招募中
入组人数
200
试验地点
1
主要终点
mGFR determined using 125I-Iothalamate and 131I-hippuran

研究概览

简要总结

To determine the equivalence of mGFR using 125I-iothalamate and 131I-hippuran versus iohexol

研究设计

研究类型
Interventional
分配方式
Not Applicable
主要目的
Second study visit (Part B)
盲法
None

入排标准

年龄范围
18 years 至 65+ years(65+ Years, 18-64 Years)
接受健康志愿者

入选标准

  • Scheduled to undergo a kidney function measurement test as part of standard care
  • Age ≥ 18 years
  • Written informed consent

排除标准

  • History of hypersensitivity to iodinated contrast media or one of the excipients in the formulation of iohexol (trometamol, sodium calcium edetate, hydrochloric acid).
  • Subjects with (suspected or known) thyrotoxicosis.
  • Pregnant women and women of child-bearing potential who are not using reliable contraception
  • Patients who are unlikely to comply to the trial’s procedure (non-compliance)

结局指标

主要结局

mGFR determined using 125I-Iothalamate and 131I-hippuran

mGFR determined using 125I-Iothalamate and 131I-hippuran

mGFR determined using iohexol

mGFR determined using iohexol

次要结局

  • Repeated mGFR using iothalamate and hippuran on a separate study day(Through study completion, an average of 1 year)
  • Repeated mGFR using iohexol on a separate study day(Through study completion, an average of 1 year)

研究者

申办方类型
Hospital/Clinic/Other health care facility
责任方
Principal Investigator
主要研究者

Ron T Gansevoort

Scientific

Universitair Medisch Centrum Groningen

研究点 (1)

Loading locations...

相似试验

method VALIDation and evaluation of non-radioactive... | 临床试验